Women may be more likely than men to be affected by anxiety, according to a new study.

Cigarette smoking may increase kidney disease risk among African-Americans, according to a new study.

The US Food and Drug Administration (FDA) has approved the first buprenorphine implant for opioid dependence.

The US Food and Drug Administration (FDA) is warning about the possibility for a rare but serious skin reaction from a particular antipsychotic.

The US Food and Drug Administration (FDA) is warning about possible impulse-control problems, such as compulsive or uncontrollable urges, tied to a particular antipsychotic.

Behavior therapy may be an underused form of treatment for children with attention deficit hyperactivity disorder (ADHD), according to the Centers for Disease Control and Prevention (CDC).

The US Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) tablets to treat hallucinations and delusions in patients with Parkinson's disease.

Certain nutritional supplements may help antidepressants do their job better in patients with depression, a new study found.

Medications that help patients quit smoking did not appear to cause serious neuropsychiatric side effects, a new study found.

The US Food and Drug Administration (FDA) is expanding its “The Real Cost” campaign to rural America.